SFSara M. Freeman

Sara M. Freeman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sara M. Freeman has a total of 196 co-authors. Here are the top co-authors by number of shared publications:

  • Karen L. Bales

    California National Primate Research Center Davis California USA

    12 shared publications
  • Karen Lisa Bales

    Department of Psychology, University of California, Davis

    10 shared publications
  • Aaron L. Smith

    Emory University

    8 shared publications
  • Larry J. Young

    Silvio O. Conte Center for Oxytocin and Social Cognition, Center for Translational Social Neuroscience, Department of Psychiatry and Behavioral Sciences, Yerkes National Primate Research Center, Emory University, 954 Gatewood Road, Atlanta, GA 30329, USA

    7 shared publications
  • Mark M. Goodman

    Emory University

    6 shared publications
  • Larry J. Young

    Department of Psychiatry and Behavioral Sciences, Silvio O. Conte Center for Oxytocin and Social Cognition, Center for Translational Social Neuroscience, Emory National Primate Research Center, Emory University

    4 shared publications

Latest Publications

  • Open Access

    Oxytocin receptor gene expression in the basal forebrain in autism: association with receptor binding levels and single nucleotide polymorphisms

    by Ethan E. Dayley, Susan Durham, Michelle C. Palumbo, Jill F. Lundell, Sara M. Freeman

    Background: The brain’s oxytocin system has been implicated in the neurobiology of autism (ASD), given the role of oxytocin in modulating social function in humans and animals more broadly. Previous work from members of our group reported dysregulation in oxytocin receptor (OXTR) binding in postmortem tissue from the basal forebrain in donors with autism compared to unaffected control donors. This study follows up on those findings by investigating the potential genetic and gene expression changes that could be driving those differences. Methods: We used adjacent sections from the same specimens from our previous study and performed duplex fluorescence in situ hybridization to visualize and quantify OXTR mRNA in the ventral pallidum (VP) and in the cholinergic magnocellular neurons of the nucleus basalis of Meynert (NBM), visualized with choline acetyltransferase ( ChAT ). We genotyped the brain samples using a SNP microarray on extracted DNA. We then used regression models to test associations between OXTR binding density, OXTR mRNA levels, and relevant OXTR SNPs. Additionally, we tested for correlations between age and OXTR mRNA. Results: ASD specimens showed significantly greater OXTR mRNA than unaffected donors in both the VP and the NBM. Furthermore, this is the first demonstration of OXTR expression in the cholinergic neurons of the human basal forebrain; 73% of OXTR signal in the images of the ChAT + neurons were colocalized with the cholinergic neurons. OXTR binding levels from our previous study were positively associated with OXTR mRNA in the NBM but only in the ChAT + neurons there. OXTR binding levels were not associated with OXTR mRNA in the VP. We genotyped all specimens for three common SNPs in the OXTR gene that have been associated with ASD in the literature, but none significantly predicted levels of OXTR binding or gene expression in the NBM or VP. OXTR mRNA levels were strongly positively correlated with donor age across regions, which was driven by ASD specimens. Conclusions: Taken together, our results contribute to a more nuanced picture triangulating variation in OXTR gene sequence, gene expression, protein levels, and human behavior. Trial registration: Clinical trial number: not applicable.


  • Open Access

    Oxytocin receptor gene expression in the basal forebrain in autism: association with receptor binding levels and single nucleotide polymorphisms

    by Ethan E. Dayley, Susan Durham, Michelle C. Palumbo, Jill F. Lundell, Sara M. Freeman

    Background: The brain’s oxytocin system has been implicated in the neurobiology of autism (ASD), given the role of oxytocin in modulating social function in humans and animals more broadly. Previous work from members of our group reported dysregulation in oxytocin receptor (OXTR) binding in postmortem tissue from the basal forebrain in donors with autism compared to unaffected control donors. This study follows up on those findings by investigating the potential genetic and gene expression changes that could be driving those differences. Methods: We used adjacent sections from the same specimens from our previous study and performed duplex fluorescent in situ hybridization to visualize and quantify OXTR mRNA in the ventral pallidum (VP) and in the cholinergic magnocellular neurons of the nucleus basalis of Meynert (NBM), visualized with choline acetyltransferase ( ChAT ). We genotyped the brain samples using a SNP microarray on extracted DNA. We then used regression models to test associations between OXTR binding density, OXTR mRNA levels, and relevant OXTR SNPs. Additionally, we tested for correlation between age and OXTR mRNA. Results: ASD specimens showed significantly greater OXTR mRNA than unaffected donors in both the VP and the NBM. Furthermore, this is the first demonstration of OXTR expression in the cholinergic neurons of the human basal forebrain; 73% of OXTR signal in the images of the ChAT+ neurons were colocalized with the cholinergic neurons. OXTR binding levels from our previous study were positively associated with OXTR mRNA in the NBM of control specimens but not in ASD specimens, implying potential dysregulation at the level of protein translation or mRNA trafficking in the NBM in ASD. OXTR binding levels were not associated with OXTR mRNA in the VP of either group. We genotyped all specimens for three common SNPs in the OXTR gene that have been associated with ASD in the literature, but none significantly predicted levels of OXTR binding or gene expression in the NBM or VP. Conclusions: Taken together, our results contribute to a more nuanced picture triangulating variation in OXTR gene sequence, gene expression, protein levels, and human behavior. Trial Registration: Clinical trial number: not applicable.

  • Neuropeptide receptor distributions in male and female Eulemur vary between female-dominant and egalitarian species

    by Allie E. Schrock, Mia R. Grossman, Nicholas M. Grebe, Annika Sharma, Sara M. Freeman, Michelle C. Palumbo, Karen L. Bales, Heather B. Patisaul, Christine M. Drea

    Aggression and its neurochemical modulators are typically studied in males, leaving the mechanisms of female competitive aggression or dominance largely unexplored. To better understand how competitive aggression is regulated in the primate brain, we used receptor autoradiography to compare the neural distributions of oxytocin and vasopressin receptors in male and female members of female-dominant versus egalitarian/codominant species within the Eulemur genus, wherein dominance structure is a reliable proxy of aggression in both sexes. We found that oxytocin receptor binding in the central amygdala (CeA) was predicted by dominance structure, with the members of three codominant species showing more oxytocin receptor binding in this region than their peers in four female-dominant species. Thus, both sexes in female-dominant Eulemur show a pattern consistent with the regulation of aggression in male rodents. We suggest that derived pacifism in Eulemur stems from selective suppression of ancestral female aggression over evolutionary time via a mechanism of increased oxytocin receptor binding in the CeA, rather than from augmented male aggression. This interpretation implies fitness costs to female aggression and/or benefits to its inhibition. These data establish Eulemur as a robust model for examining neural correlates of male and female competitive aggression, potentially providing novel insights into female dominance.

  • Oxytocin and vasopressin 1a receptor alterations in the superior temporal sulcus and hypothalamus in schizophrenia

    by Ariel W. Snowden, Sarah E. Schwartz, Aaron L. Smith, Mark M. Goodman, Sara M. Freeman

    Schizophrenia is a severe psychiatric condition marked by social impairments. Given that social cognitive functioning strongly predicts life outcomes in schizophrenia, understanding its neurobiological basis is crucial. This study used receptor autoradiography to measure vasopressin 1a (AVPR1a) and oxytocin receptor (OXTR) densities in postmortem brain tissue from individuals with schizophrenia (N = 23) and matched controls (N = 18). We focused on the superior temporal sulcus, a region involved in social perception and often impaired in schizophrenia. AVPR1a binding densities exceeded those of OXTR. Notably, AVPR1a densities increased with age in females with schizophrenia, which may explain age-related changes in positive symptom severity (e.g. paranoia) in this group. Additionally, schizophrenia was associated with increased OXTR and a trend toward higher AVPR1a densities in the hypothalamus, a region central to oxytocin and vasopressin synthesis and stress response regulation. These findings suggest compensatory upregulation of nonapeptide receptor systems due to potentially reduced oxytocin and vasopressin release. Overall, our results highlight age- and sex-dependent alterations in receptor binding, providing insights into the neurobiology of social dysfunction in schizophrenia.


  • Open Access

    Age, pair tenure and parenting, but not face identity, predict looking behaviour in a pair-bonded South American primate

    by Allison R. Lau, Alexander Baxter, Shuyu He, Louise Loyant, Chelsea A. Ortiz-Jimenez, Melissa D. Bauman, Karen L. Bales, Sara M. Freeman


  • Internal and external factors affect pair mate proximity in captive coyotes, Canis latrans

    by Alexandra Turano, Stacey P. Brummer, Jeffrey T. Schultz, Julie K. Young, Sara M. Freeman


  • Binding Affinity, Selectivity, and Pharmacokinetics of the Oxytocin Receptor Antagonist L-368,899 in the Coyote (Canis latrans)

    by Sara M Freeman, J Leon Catrow, James Eric Cox, Alexandra Turano, McKenna A Rich, Hillary P Ihrig, Naveena Poudyal, Cheng-Wei Tom Chang, Eric M Gese, Julie K Young, et al.

    L-368,899 is a selective small-molecule oxytocin receptor (OXTR) antagonist originally developed in the 1990s to prevent preterm labor. Although its utility for that purpose was limited, L-368,899 is now one of the most commonly used drugs in animal research for the selective blockade of neural OXTR after peripheral delivery. A growing number of rodent and primate studies have used L-368,899 to evaluate whether certain behaviors are oxytocin dependent. These studies have improved our understanding of oxytocin’s function in the brains of rodents and monkeys, but very little work has been done in other mammals, and only a single paper in macaques has provided any evidence that L-368,899 can be detected in the CNS after peripheral delivery. The current study sought to extend those findings in a novel species: coyotes (Canis latrans). Coyotes are ubiquitous North American canids that form long-term monogamous pair-bonds. Although monogamy is rare in rodents and primates, all wild canid species studied to date exhibit social monogamy. Coyotes are therefore an excellent model organism for the study of oxytocin and social bonds. Our goal was to determine whether L-368,899 is a viable candidate for future use in behavioral studies in coyotes. We used captive coyotes at the USDA National Wildlife Research Center’s Predator Research Facility to evaluate the pharmacokinetics of L-368,899 in blood and CSF during a 90-min time course after intramuscular injection. We then characterized the binding affinity and selectivity of L-368,899 to coyote OXTR and the structurally similar vasopressin 1a receptor. We found that L-368,899 peaked in CSF at 15 to 30 min after intramuscular injection and slowly accumulated in blood. L-368,899 was 40 times more selective for OXTR than vasopressin 1a receptors and bound to the coyote OXTR with an affinity of 12 nM. These features of L-368,899 support its utility in future studies to probe the oxytocin system of coyotes.


  • Intranasal oxytocin does not change partner preference in female titi monkeys (Plecturocebus cupreus), but intranasal vasopressin decreases it

    by Pauline Zablocki‐Thomas, Allison Lau, Lynea Witczak, Madison Dufek, Amber Wright, Logan Savidge, John Paulus, Alexander Baxter, Chloe Karaskiewicz, Adele M. H. Seelke, et al.

    Strong social bonds are critical to human health; however, the mechanisms by which social bonds are formed and maintained are still being elucidated. The neurohormones oxytocin (OT) and vasopressin (AVP) are considered likely candidates. Primate females, both human and nonhuman, remain understudied populations. Here, we conducted a pharmacological study coupled with a behavioral partner preference test (PPT) to better understand the mechanistic basis of attachment in adult female titi monkeys (Plecturocebus cupreus). This pair‐bonding species shares a conserved form of oxytocin with humans and is an excellent model organism to study the neural basis of social bonding. We performed intranasal administration of three doses of oxytocin (IN‐OT), two doses of vasopressin (IN‐AVP), one dose of an oxytocin antagonist (IN‐OTA) and one dose of a saline treatment. We found that compared to the saline control, the IN‐AVP treatment (lower dose, 40 IU/kg) decreased the time spent in proximity to the partner and increased lip‐smacking toward the stranger. We found no effects of IN‐OT or IN‐OTA manipulation on partner preference. In contrast, low‐dose IN‐AVP weakened the partner preference in female titi monkeys.